Omnipresent - Interviews

Filter By Therapeutic Area

Reproductive Health

Allergy & Immunology

Gastroenterology

Interventional Cardiology

Microbiology & Infectious Diseases

Filter By Content Type

An Interview with Prof Thierry Troosters – President of ERS

An Interview with Dr George J. Hruza – President of AAD 2019–2020

An Interview with Skin Specialist Dr Chytra V. Anand

“Even the smallest steps help in bringing us closer to our goal”

Insights from Prof Robert Langer, the Most Cited Engineer in History

Doctor Scott Lilly

Professor David E. Lanfear

Yann Le Cam CEO of EURORDIS-Rare Diseases Europe

In Vitro Fertilisation and Covid-19: Insights From An Embryologist

Reproductive Health

“We need to get better at putting the patient at the centre of what we do”

“Collaboration and sharing of knowledge are critical in this industry”

We have to change our practice if we want better results

“In cross-functional teams it’s important to manage conflict and have difficult conversations with employees”

The Potential of Biomedical Engineering in Respiratory Health

“Good innovation requires empathy, passion, and an entrepreneurial spirit”

“The Nordics are a very enabling ecosystem; many stakeholders are travelling in the same direction as us to support VBHC.”

Curious Future Insight Conference and the Future Insight Prize: Merck’s Fight for a Better Tomorrow

“The world is moving fast in medical affairs”

The role of biomarker testing in treatment decision making: Current and future perspectives

Combatting the Burden of Atrial Fibrillation

“We all need a North Star: to keep us true, on track, inspired, and working tirelessly towards what we want to achieve”

“Medical Affairs has a Central Role to Play in Building Trust Between Doctors and Healthcare Stakeholders and the Pharmaceutical Industry”

“For us it’s about more than just selling the products – we want to be a responsible partner in society”

Patient engagement is now essential, not only in order to develop new drugs but also to provide insights for medicines that are already approved and on the market

“We need to move from the idea people have today – that digital just enables you to do things slightly better – to looking at the potential of doing completely new things”

The Legacy of Sheila Sherlock in Hepatology

“We Want to Cover an Entire Therapeutic Spectrum, Helping Patients to Become Owners of their Conditions Alongside Dermatologists”

Advancements and Trends in Urology